Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
92,070,273
-
Share change
-
-1,258,306
-
Total reported value
-
$9,405,178,680
-
Put/Call ratio
-
77%
-
Price per share
-
$102.15
-
Number of holders
-
484
-
Value change
-
-$118,631,518
-
Number of buys
-
241
-
Number of sells
-
181
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2014
As of 30 Sep 2014 Edwards Lifesciences Corp - Common Stock (EW) had 484 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 92,070,273 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, VANGUARD GROUP INC, Capital World Investors, GENERATION INVESTMENT MANAGEMENT LLP, FMR LLC, State Street Corp, WELLINGTON MANAGEMENT CO LLP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and NORTHERN TRUST CORP.
This table shows 484 institutional shareholders of the security as of 30 Sep 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.